Filtern
Volltext vorhanden
- ja (37)
Gehört zur Bibliographie
- ja (37)
Erscheinungsjahr
Dokumenttyp
Sprache
- Englisch (37)
Schlagworte
- osteoporosis (4)
- hypophosphatasia (3)
- mechanotransduction (3)
- mineralization (3)
- sarcopenia (3)
- HPP (2)
- LMHFV (2)
- Mesenchymal stem cells (2)
- Multiple myeloma (2)
- TNAP (2)
- back pain (2)
- bone-mineral density (2)
- differentiation (2)
- exercise (2)
- fracture (2)
- fracture healing (2)
- in-vitro (2)
- inflammation (2)
- model (2)
- nervous system (2)
- oestrogen receptor signalling (2)
- stromal cells (2)
- teriparatide (2)
- 2',7'-dichlorofluorescin (1)
- 3D printing (1)
- ALPL (1)
- Angiopoietin-like 4 (1)
- Bioreaktor (1)
- Bisphosphonates (1)
- Bone Mineral Density (1)
- Bone disease (1)
- Breast cancer cells (1)
- CCN1 (1)
- Caspase 3/7 activity (1)
- Cell viability, (1)
- EQ-5D (1)
- ER signaling (1)
- Endothelial growth-factor (1)
- Gene expression profiling (1)
- Hypophosphatasia (1)
- Mechanical strain (1)
- Medizin (1)
- Novobiocin (1)
- Osteogenic precursor cells (1)
- Probenecid (1)
- RT-PCR (1)
- Splicing (1)
- WNT pathway (1)
- WNT signaling pathway (1)
- WNT5A (1)
- Wnt (1)
- Wnt signalling (1)
- Wnt-signalling (1)
- Wnt/β-catenin signaling (1)
- additive manufacturing (1)
- age (1)
- age-related osteoporosis (1)
- aging (1)
- alendronate (1)
- alkaline phosphatase (1)
- alkaline-phosphatase (1)
- alpha (1)
- angiogenic cytokines (1)
- aseptic loosening (1)
- asfotase alfa (1)
- autologous chondrocyte implantation (1)
- autosomal-dominant osteopetrosis (1)
- biceps tendon (1)
- biodegradable polymers (1)
- biomarkers Myelomas (1)
- bioreactor (1)
- bisphosphonates (1)
- bone (1)
- bone QCT (1)
- bone biology (1)
- bone formation (1)
- bone imaging (1)
- bone marrow (1)
- bone marrow lesion/edema (1)
- bone marrow stromal cells (1)
- bone mineral density (1)
- bone remodeling (1)
- bone tumour (1)
- cancer microenvironment (1)
- cardiovascular (1)
- cells (1)
- cellular signalling networks (1)
- click chemistry (1)
- colony-stimulating factor (1)
- community-dwelling (1)
- computer modelling (1)
- core depression (1)
- craniosynostosis (1)
- database (1)
- early stage (1)
- epidermal growth factor (1)
- expression (1)
- fluorescence microscopy (1)
- fluorescent dyes (1)
- gene (1)
- gene constructs (1)
- gene-expression (1)
- glycocalyx (1)
- growth factor (1)
- hMSC-TERT (1)
- health-related quality of life (1)
- high-bone-mass (1)
- homeostasis (1)
- human atherosclerotic lesions (1)
- hypovitaminosis D (1)
- impact (1)
- in situ guided tissue regeneration (1)
- in situ hybridization (1)
- in vitro (1)
- level mechanical vibrations (1)
- lines (1)
- malignancy (1)
- marrow stromal cells (1)
- mechanosensing (1)
- mechanosensitive reporter (1)
- men (1)
- mesenchymal cells (1)
- mesenchymal stem cell (1)
- mesenchymal stem cells (1)
- mesenchymal stem-cells (1)
- mesenchymal stromal cells (1)
- mesenchymal tissues (1)
- metaanalysis (1)
- metabolic glycoengineering (1)
- metabolic risk (1)
- metabolic syndrome (1)
- metabolism (1)
- microstructures (1)
- mineraliztion (1)
- modified monosaccharides (1)
- monoclonial gammopathy (1)
- morphogenetic protein (1)
- multiple myeloma Lesions (1)
- muscle (1)
- mutant mice (1)
- mutations (1)
- myeloma (1)
- myeloma cells (1)
- myokines (1)
- nanostructures (1)
- neurotransmission (1)
- nonspecific alkaline-phosphae (1)
- obesity (1)
- older people (1)
- osteoblastic cells (1)
- osteochondral allografts (1)
- osteoclasts (1)
- osteogenesis imperfecta (1)
- osteogenic differentiation (1)
- osteokines adaptation (1)
- osteomalacia (1)
- osteopenia (1)
- ovariectomized rats (1)
- ovariectomy (1)
- overview (1)
- oxidative stress (1)
- parathyroid-hormone (1)
- peripheral-blood (1)
- persistence (1)
- perspectives (1)
- precedes multiple-myeloma (1)
- prevalent fractures (1)
- progenitor cells (1)
- proliferation (1)
- promotes (1)
- quality of life (1)
- rare bone disease (1)
- receptor beta (1)
- receptor related protein (1)
- regenerative capacity (1)
- regenerative medicine (1)
- replacement therapy (1)
- replicative senescence (1)
- resistance exercise (1)
- responsiveness (1)
- rickets (1)
- scaffolds (1)
- segmental collapse (1)
- senescence (1)
- senescence‐associated secretory phenotype (1)
- serum amyloid A (1)
- sheep model (1)
- shoulder (1)
- signaling (1)
- skeletal overexpression (1)
- stem cells (1)
- teeth (1)
- tendon-derived stem cell (1)
- tissue (1)
- tissue engineering (1)
- toll-like receptor (1)
- transcription factors (1)
- tumour malignancy (1)
- undetermined significance (1)
- vertebral fractures (1)
- vertebrate (1)
- vitamin D (1)
- vitamin D deficiency (1)
- vitamin-D-receptor (1)
- whole body vibration (1)
- whole-body electromyostimulation (1)
- whole-body vibration (1)
- zebrafish (1)
- zoledronic acid (1)
Institut
- Lehrstuhl für Orthopädie (37)
- Medizinische Klinik und Poliklinik II (4)
- Institut für Humangenetik (3)
- Kinderklinik und Poliklinik (3)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Fakultät für Mathematik und Informatik (1)
- Institut für Molekulare Infektionsbiologie (1)
EU-Projektnummer / Contract (GA) number
- 241719 (1)
- 242175 (1)
- 617989 (1)
- EU-1650-0006 (1)
1,25-dihydroxyvitamin D3 (1,25D3) was reported to induce premature organismal aging in fibroblast growth factor-23 (Fgf23) and klotho deficient mice, which is of main interest as 1,25D3 supplementation of its precursor cholecalciferol is used in basic osteoporosis treatment. We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC). Effects of 100 nM 1,25D3 on hMSC were analyzed by cell proliferation and apoptosis assay, beta-galactosidase staining, VDR and surface marker immunocytochemistry, RT-PCR of 1,25D3-responsive, quiescence-and replicative senescence-associated genes. 1,25D3 treatment significantly inhibited hMSC proliferation and apoptosis after 72 h and delayed the development of replicative senescence in long-term cultures according to beta-galactosidase staining and P16 expression. Cell morphology changed from a fibroblast like appearance to broad and rounded shapes. Long term treatment did not induce lineage commitment in terms of osteogenic pathways but maintained their clonogenic capacity, their surface marker characteristics (expression of CD73, CD90, CD105) and their multipotency to develop towards the chondrogenic, adipogenic and osteogenic pathways. In conclusion, 1,25D3 delays replicative senescence in primary hMSC while the pro-aging effects seen in mouse models might mainly be due to elevated systemic phosphate levels, which propagate organismal aging.